Hopkins scientist to direct international studies of antibiotic
as new treatment for tuberculosis
October 18, 2005
Credit Pacific Service Union If successful, moxifloxacin could be first new treatment for TB
in more than 40 years
A study reported in Dermatology (2001, volume 203, issue 2, page 40) evaluated he place of zinc gluconate in relation to antibiotics in the treatment of acne vulgaris.
Credit First Service Union A Johns Hopkins infectious disease expert will lead two
international studies of the effectiveness of the antibiotic
moxifloxacin as a new treatment for tuberculosis, the highly
contagious bacterial disease that kills more than 2 million people
worldwide each year and is the leading cause of death of people
living with HIV and AIDS.
Moxifloxacin is currently approved in more than 100 countries,
including the United States, as a treatment for bacterial
respiratory infections, such as bronchitis, sinusitis and
pneumonia.
As soaring temperatures hit the UK, Britons are spending more on their credit cards and living a more Mediterranean lifestyle, according to a new study.
Card Credit Mobile Service "Defeating the spread of tuberculosis in the United States and
the developing world will require scientists to take bold and
creative new approaches because there has not been a new therapy
for tuberculosis in more than 40 years," says tuberculosis expert
Richard Chaisson, M.D., a professor of medicine, epidemiology and
international
health at The Johns Hopkins
University School of Medicine.
Credit card provider Barclaycard has launched a new text alert service to remind customers when their monthly payment is due.
Card Credit Discover Service Chaisson will conduct the research as part of a series of
studies on moxifloxacin that are being coordinated by the nonprofit
Global Alliance for TB Drug Development (GATB) in collaboration
with Bayer Healthcare AG, the drug's maker. His research will
assess the ability of moxifloxacin to shorten the treatment period
required to cure the disease.
- New Personal Loan Gold Service (credit repair included) Clean Up Your Credit Report Remove negative items from your credit report and your credit score goes up!
Credit Public Service Union One of Chaisson's studies will take place in Brazil, with
support from the U.S. Food and Drug Administration's Office of
Orphan Product Development. He will co-direct the second study with
Susan Dorman, M.D., an assistant professor at Hopkins, and John
Johnson, M.D., of Case Western Reserve University. The study will
take place in five countries-the United States, Canada, Brazil,
Spain, South
Africa and Uganda-with
funding support from the U.S.
Centers for Disease Control and Prevention's TB Trials
Consortium. (Maryland is one of the 10 U.S. states where the
second study will take place.)
Should you reach us after hours, please leave a message detailing your credit service needs, and a credit repair specialist will return your call shortly. mail to our Credit Repair Specialists... Please direct inquiries to our Credit Report Repair Specialists for all of your credit service needs, or if you have questions about our credit repair program. Se habla espaÉl.
Card Credit Processing Service The overall research program, expected to last two to three
years and enroll close to 2,500 patients worldwide, was to be
announced today at a news conference during the 36th annual World
Conference on Lung Health in Paris, France. Other related studies
of moxifloxacin will be led by Stephen Gillespie, M.D., of the
University College-London, and Andrew Nunn, M.D., of the British
Medical Research Council.
Center Credit Service Union The GATB estimates that 1 billion people worldwide will be
infected with tuberculosis by the year 2020, of whom 200 million
will fall ill and 35 million will die. The group is developing
moxifloxacin and other drugs in an effort to cure more patients by
shortening the length of time it takes to treat the disease.
Card Credit Service Wireless "Shortening the time required to cure the disease could save
millions of lives in the coming years," Chaisson says.
Credit Security Service Union Chaisson has more than two decades of experience researching the
tuberculosis epidemic, especially its impact on the health of
people in developing countries, where most of the 9 million new
cases of the disease occur each year. Current treatments for
tuberculosis, Chaisson says, consist of a regimen of four
antibiotic drugs usually, but not always, given in view of a
caregiver. Called Directly Observed Therapy Short-Course, or DOTS,
the drugs must be taken several times daily for six to eight
months. Although DOTS cures 95 percent of those treated, the
lengthy treatment period has proven a problem for patients, who
sometimes miss taking their drugs on time, minimizing the therapy's
effectiveness.
Credit Report Service Chaisson notes that multidrug-resistant strains of the tubercle
bacillus, formally known as Mycobacterium tuberculosis, are
spreading at a rate of 300,000 newly diagnosed cases each year that
cannot be treated by current drugs. "New options are needed, and
they need to be both effective and easier for patients to
tolerate," he adds.
Blogspot Com Christian Chaisson says that substituting moxifloxacin for one of the key
ingredients in DOTS could shorten the treatment period by nearly
two months, to three to four months, making the form far less
costly overall.
Christian Counseling Credit As part of the research program, Bayer has agreed to donate
supplies of moxifloxacin for all of the trial sites, including
those in Tanzania and Zambia that are part of a third study not
involving Hopkins. The TB Alliance will coordinate the trial and
cover study costs, with additional support from the European and
Developing Countries Clinical Trials Partnership.
Credit Federal Service Union In addition to the moxifloxacin study, Chaisson directs the
Hopkins-based Consortium to Respond Effectively to the AIDS/TB
Epidemic, called CREATE, an international effort to control the
spread of tuberculosis and treat the disease in countries hit most
hard by the duel epidemics. CREATE, which is sponsored by the Bill
and Melinda Gates Foundation, has three community-based studies
under way in Africa and Brazil.
Credit Monitoring Service Johns Hopkins Medical Institutions
[ Comment, Edit or Article Submission ]